Kanada - inglise - Health Canada

fruit of the earth, inc - octinoxate; octocrylene - cream - 7.5%; 2% - octinoxate 7.5%; octocrylene 2% - sunscreen agents

Kanada - inglise - Health Canada

johnson & johnson inc - avobenzone; oxybenzone; octisalate - lotion - 2.0%; 4.0%; 4.0% - avobenzone 2.0%; oxybenzone 4.0%; octisalate 4.0% - sunscreen agents

Kanada - inglise - Health Canada

fruit of the earth, inc - avobenzone; octinoxate; octisalate - lotion - 3%; 7%; 5% - avobenzone 3%; octinoxate 7%; octisalate 5% - sunscreen agents

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

bryant ranch prepack - bupropion hydrochloride (unii: zg7e5poy8o) (bupropion - unii:01zg3tpx31) - bupropion hydrochloride 75 mg - bupropion hydrochloride tablets are indicated for the treatment of major depressive disorder (mdd), as defined by the diagnostic and statistical manual (dsm). the efficacy of bupropion hydrochloride tablets in the treatment of a major depressive episode was established in two 4-week controlled inpatient trials and one 6-week controlled outpatient trial of adult subjects with mdd [see clinical studies (14)]. - bupropion hydrochloride tablets are contraindicated in patients with a seizure disorder. - bupropion hydrochloride tablets are contraindicated in patients with a current or prior diagnosis of bulimia or anorexia nervosa as a higher incidence of seizures was observed in such patients treated with bupropion hydrochloride tablets [see warnings and precautions (5.3)]. - bupropion hydrochloride tablets are contraindicated in patients undergoing abrupt discontinuation of alcohol, benzodiazepines, barbiturates, and antiepileptic drugs [see warnings and precautions (5.3) , drug interactions (7.3)].  - th

Kanada - inglise - Health Canada

avalon natural products - octinoxate; oxybenzone; avobenzone - lotion - 7.0%; 4.0%; 3.0% - octinoxate 7.0%; oxybenzone 4.0%; avobenzone 3.0% - sunscreen agents

Kanada - inglise - Health Canada

norwood packaging ltd - octinoxate; octisalate; oxybenzone - lotion - 7.5%; 5.0%; 4.0% - octinoxate 7.5%; octisalate 5.0%; oxybenzone 4.0% - sunscreen agents

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

sunlessandbeauty pty ltd - 58786 - hair-removal diode laser system - diode laser designed to remove unwanted body hair (e.g., armpit, leg/arm, back, chest, bikini line, and face)

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

supergoop llc - avobenzone (unii: g63qqf2nox) (avobenzone - unii:g63qqf2nox), homosalate (unii: v06sv4m95s) (homosalate - unii:v06sv4m95s), octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51), octisalate (unii: 4x49y0596w) (octisalate - unii:4x49y0596w) - uses - helps prevent sunburn - if used as directed with other sun protection measures (see directions), decreases the risk of skin cancer and early skin aging caused by the sun stop use and ask a doctor if rash occurs.

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

supergoop, llc - avobenzone 2%, homosalate 10%, octinoxate 5%, octisalate 5% - sunscreen - helps prevent sunburn - if used as directed with other sun protection measures (see directions), decreases the risk of skin cancer and early skin aging caused by the sun

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

contract pharmacy services-pa - bupropion hydrochloride (unii: zg7e5poy8o) (bupropion - unii:01zg3tpx31) - bupropion hydrochloride 75 mg - bupropion hydrochloride tablets are indicated for the treatment of major depressive disorder (mdd), as defined by the diagnostic and statistical manual (dsm). the efficacy of bupropion hydrochloride tablets in the treatment of a major depressive episode was established in two 4-week controlled inpatient trials and one 6-week controlled outpatient trial of adult subjects with mdd [see clinical studies ( 14)]. - bupropion hydrochloride tablets are contraindicated in patients with a seizure disorder. - bupropion hydrochloride tablets are contraindicated in patients with a current or prior diagnosis of bulimia or anorexia nervosa as a higher incidence of seizures was observed in such patients treated with bupropion hydrochloride tablets [see warnings and precautions ( 5.3)]. - bupropion hydrochloride tablets are contraindicated in patients undergoing abrupt discontinuation of alcohol, benzodiazepines, barbiturates, and antiepileptic drugs